Medical Xpress EORTC trial 40084-22084 has two primary objectives: to determine if adding erlotinib to gemcitabine adjuvant chemotherapy will improve survival as compared to gemcitabine alone following resection of head of pancreas adenocarcinoma, then, following ... and more »
Winnipeg Free Press It's now known that the Marchese bags containing cyclophosphamide and gemcitabine had too much saline, in effect watering down the prescribed drug ...
Motley Fool The most significant new information related to progression-free survival and overall survival rates. Celgene announced that patients taking Pomalyst with low-dose dexamethasone achieved a median progression-free survival rate of 4 months and a median ... and more »
Pharmacy Europe Consistent with LUX-Lung 3, afatinib* treatment led to significant and sustained tumour shrinkage compared to chemotherapy ( gemcitabine / cisplatin) in LUX-Lung 6. Specifically, in approximately two thirds of patients (66.9%) taking afatinib*, the ... and more »
MarketWatch In the second study, results from a randomized Phase II trial of bavituximab plus gemcitabine in patients with non-resectable Stage IV pancreatic cancer demonstrated more than a doubling of the overall response rate (ORR) and an improvement in overall ...
Cancer Network There were 183 patients in an experimental arm and 92 patients in a control arm; the control group all received gemcitabine and carboplatin. The experimental arm was divided into four subgroups based on protein expression: Low levels of both proteins ...
